From: Eye movement impairments in Parkinson's disease: possible role of extradopaminergic mechanisms
CTL | PD-DA | PD-DBS | ||
---|---|---|---|---|
on | off | |||
Number of subjects total (male, female) | 23 (18m, 5f) | 34 (21m, 13f) | 14 ( 9m, 5f) | |
Age (yrs) mean (± SD), range | 61.7 (± 7.1), 49-76 | 63.0 (± 11.7), 36-81 | 64.2 (± 7.1), 50-74 | |
Disease duration (yrs) mean (± SD), range | 6.9 (± 4.4), 1-16 | 10.5 (± 4.0), 4-19 | ||
Levodopa equivalent medication (mg/day) mean (± SD), range | 917 (± 578), 200-2650 | 509 (± 348), 0-1250 | ||
UPDRS motor scale mean (± SD), range | 20.3 (± 13.0), 2-56 | 29, 0 (± 16.3), 5-62 | 38.8 (± 14.3), 16-64 |